An investigation into the human serum "interactome"

被引:255
作者
Zhou, M
Lucas, DA
Chan, KC
Issaq, HJ
Petricoin, EF
Liotta, LA
Veenstra, TD
Conrads, TR
机构
[1] SAIC Frederick Inc, Natl Canc Inst, Lab Proteom & Analyt Technol, Frederick, MD 21702 USA
[2] US FDA, Ctr Biol Evaluat & Res, Natl Canc Inst, Clin Proteom Program, Bethesda, MD 20014 USA
[3] NCI, Ctr Canc Res, Pathol Lab, Bethesda, MD 20892 USA
关键词
albumin; biomarker; human serum; proteome; surface-enhanced laser desorption/ionization;
D O I
10.1002/elps.200405866
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The protein content of human serum is composed of a millieu of proteins from almost every type of cell and tissue within the body. The serum proteome has been shown to contain information that directly reflects pathophysiological states and represents an invaluable source of diagnostic information for a variety of different diseases. Unfortunately, the dynamic range of protein abundance, ranging from much greater than mg/mL level to much less than pg/mL level, renders complete characterization of this proteome nearly impossible with current analytical methods. To study low-abundance proteins, which have potential value for clinical diagnosis, the high-abundant species, such as immunoglobulins and albumin, are generally eliminated as the first step in many analytical protocols. This step, however, is hypothesized to concomitantly remove proteins/peptides associated with the high-abundant proteins targeted for depletion. In this study, immunoprecipitation was combined with microcapillary reversed-phase liquid chromatography (muRPLC) coupled on-line with tandem mass spectrometry (MS/MS) to investigate the low-molecular-weight proteins/peptides that associate with the most abundant species in serum. By this targeted isolation of select highly abundant serum proteins, the associated proteins/peptides can be enriched and effectively identified by muRPLC-MS/MS. Among the 210 proteins identified, 73% and 67% were not found in previous studies of the low-molecular-weight or whole-serum proteome, respectively.
引用
收藏
页码:1289 / 1298
页数:10
相关论文
共 49 条
[1]  
Adam BL, 2002, CANCER RES, V62, P3609
[2]   Toward a human blood serum proteome - Analysis by multidimensional separation coupled with mass spectrometry [J].
Adkins, JN ;
Varnum, SM ;
Auberry, KJ ;
Moore, RJ ;
Angell, NH ;
Smith, RD ;
Springer, DL ;
Pounds, JG .
MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (12) :947-955
[3]   The human plasma proteome - History, character, and diagnostic prospects [J].
Anderson, NL ;
Anderson, NG .
MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (11) :845-867
[4]  
Ardekani Ali M, 2002, Expert Rev Mol Diagn, V2, P312, DOI 10.1586/14737159.2.4.312
[5]   Differential expression of ryanodine receptor RyR2 mRNA in the non-pregnant and pregnant human myometrium [J].
Awad, SS ;
Lamb, HK ;
Morgan, JM ;
Dunlop, W ;
Gillespie, JI .
BIOCHEMICAL JOURNAL, 1997, 322 :777-783
[6]   Biology of prostate-specific antigen [J].
Balk, SP ;
Ko, YJ ;
Bubley, GJ .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (02) :383-391
[7]   Down syndrome congenital heart disease: A narrowed region and a candidate gene [J].
Barlow, GM ;
Chen, XN ;
Shi, ZY ;
Lyons, GE ;
Kurnit, DM ;
Celle, L ;
Spinner, NB ;
Zackai, E ;
Pettenati, MJ ;
Van Riper, AJ ;
Vekemans, MJ ;
Mjaatvedt, CH ;
Korenberg, JR .
GENETICS IN MEDICINE, 2001, 3 (02) :91-101
[8]   An unidentified pancreatic cancer cell product, alters some intracellular pathways of glucose metabolism in isolated rat hepatocytes [J].
Basso, D ;
Valerio, A ;
Brigato, L ;
Panozzo, MP ;
Miola, M ;
Lucca, T ;
Ujka, F ;
Zaninotto, M ;
Avogaro, A ;
Plebani, M .
PANCREAS, 1997, 15 (02) :132-138
[9]   Advances in prenatal screening for Down syndrome: II first trimester testing, integrated testing, and future directions [J].
Benn, PA .
CLINICA CHIMICA ACTA, 2002, 324 (1-2) :1-11
[10]  
Birckbichler PJ, 2000, CANCER-AM CANCER SOC, V89, P412, DOI 10.1002/1097-0142(20000715)89:2<412::AID-CNCR29>3.0.CO